[The Value of CD200 in Differential Diagnosis of Classic Hairy Cell Leukemia and Variant Hairy Cell Leukemia]

Overview

Journal Zhonghua Xue Ye Xue Za Zhi

Specialty Hematology

Date 2023 Dec 4

PMID 38049324

Authors

J Yu

S S Zhao

X Chen

C Qiao

R Wang

J Y Li

Y J Wu

Affiliations

Soon will be listed here.

References

Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748. PMC: 9214472. DOI: 10.1038/s41375-022-01620-2. View

Summers T, Jaffe E . Hairy cell leukemia diagnostic criteria and differential diagnosis. Leuk Lymphoma. 2011; 52 Suppl 2:6-10. PMC: 6331060. DOI: 10.3109/10428194.2011.565435. View

Sabattini E, Bacci F, Sagramoso C, Pileri S . WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010; 102(3):83-7. View

Palumbo G, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S . CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res. 2009; 33(9):1212-6. DOI: 10.1016/j.leukres.2009.01.017. View

Brown N, Betz B, Weigelin H, Elenitoba-Johnson K, Lim M, Bailey N . Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia. Am J Clin Pathol. 2014; 143(1):89-99. DOI: 10.1309/AJCPDN4Q1JTFGCFC. View

Shao H, Calvo K, Gronborg M, Tembhare P, Kreitman R, Stetler-Stevenson M . Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res. 2013; 37(4):401-409. PMC: 5575750. DOI: 10.1016/j.leukres.2012.11.021. View

Swerdlow S, Campo E, Pileri S, Lee Harris N, Stein H, Siebert R . The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20):2375-90. PMC: 4874220. DOI: 10.1182/blood-2016-01-643569. View

Polderdijk M, Heron M, Kuipers S, Rijkers G . Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment. Expert Rev Clin Immunol. 2019; 15(8):857-867. DOI: 10.1080/1744666X.2019.1641405. View

Pillai V, Pozdnyakova O, Charest K, Li B, Shahsafaei A, Dorfman D . CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders. Am J Clin Pathol. 2013; 140(4):536-43. DOI: 10.1309/AJCPEBK31VQQNDDR. View

10.

Falay M, Afacan Ozturk B, Gunes K, Kalpakci Y, Dagdas S, Ceran F . The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma. Turk J Haematol. 2017; 35(2):94-98. PMC: 5972347. DOI: 10.4274/tjh.2017.0085. View

11.

Sandes A, Chauffaille M, Oliveira C, Maekawa Y, Tamashiro N, Takao T . CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom. 2013; 86(2):98-105. DOI: 10.1002/cyto.b.21128. View

12.

Gupta R, Yadav S, Mittal N, Rahman K, Sharma A, Gupta A . Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature. J Cancer Res Ther. 2020; 16(1):120-126. DOI: 10.4103/jcrt.JCRT_920_17. View

13.

DArena G, De Feo V, Pietrantuono G, Seneca E, Mansueto G, Villani O . CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance. Front Oncol. 2020; 10:584427. PMC: 7727446. DOI: 10.3389/fonc.2020.584427. View

14.

Paillassa J, Safa F, Troussard X . Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib. Ther Adv Hematol. 2022; 13:20406207221090886. PMC: 9016521. DOI: 10.1177/20406207221090886. View

15.

Grever M, Abdel-Wahab O, Andritsos L, Banerji V, Barrientos J, Blachly J . Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2016; 129(5):553-560. PMC: 5290982. DOI: 10.1182/blood-2016-01-689422. View

16.

Sherman M, Hanson C, Hoyer J . An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol. 2011; 136(3):390-9. DOI: 10.1309/AJCP5GE1PSBMBZTW. View

17.

Maitre E, Wiber M, Cornet E, Troussard X . [Hairy cell leukemia]. Presse Med. 2019; 48(7-8 Pt 1):842-849. DOI: 10.1016/j.lpm.2019.07.026. View

18.

Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E . CD200 is a new prognostic factor in multiple myeloma. Blood. 2006; 108(13):4194-7. DOI: 10.1182/blood-2006-06-029355. View

19.

Matutes E . Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?. Expert Rev Hematol. 2021; 14(4):355-363. DOI: 10.1080/17474086.2021.1908121. View

20.

Araujo T, Soares Mota S, Ferreira H, Alves Ribeiro M, Goulart L, Vecchi L . Annexin A1 as a Regulator of Immune Response in Cancer. Cells. 2021; 10(9). PMC: 8464935. DOI: 10.3390/cells10092245. View